Beranda › Diabetes › New York › New York City
Uji klinis Diabetes di New York City, NY
17 studi untuk Diabetes mencari peserta di lokasi sekitar New York City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Menerima pesertaFase 3
- Weill Cornell Medicine - Comprehensive Weight Control Center, New York
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Menerima pesertaFase 1/2
- Hassenfield Children's Hospital, New York
- NYU Langone Diabetes & Endocrine Associates, New York
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Menerima pesertaFase 3
- Kailera Clinical Site, New York
APP-MNT: App-Enhanced Medical Nutrition Therapy on Glycemic Outcomes and Quality of Life
Menerima peserta
- Weill Cornell Medicine, New York
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
Menerima pesertaFase 2
- Columbia University Irving Medical Center, New York
- Icahn School of Medicine at Mount Sinai, New York
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
Menerima pesertaFase 4
- Columbia University Irving Medical Center, New York
ED Diabetes Screening and Outpatient Care - Aim 3
Menerima peserta
- NYU Langone Health, New York
Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)
Menerima peserta
- Maternal-Fetal Medicine at NYU Langone Obstetrics & Gynecology Associates, New York
A Study of a Weight Loss Intervention in People With Endometrial Cancer
Menerima pesertaFase awal 1
- Memorial Sloan Kettering Cancer Center, New York
CHIME: Comparing Health Interventions for Maternal Equity
Menerima pesertaSukarelawan sehat diterima
- Columbia University Medical Center, New York
- NYU Langone Health, New York
Transformative Research in Diabetic Nephropathy
Menerima pesertaStudi observasional
- Mount Sinai Hospital, New York
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
Menerima pesertaFase 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Menerima pesertaStudi observasional
- Columbia University Cystic Fibrosis Program, New York
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Columbia University Medical Center, New York
- Virtual Site (Remote enrollment), New York
Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels
Menerima pesertaFase 1
- Columbia University Irving Medical Center, New York
Rare and Atypical Diabetes Network
Menerima pesertaStudi observasional
- Columbia University, New York
NYSCF Scientific Discovery Biobank
Menerima pesertaStudi observasional
- New York Stem Cell Foundation Research Institute, New York
Uji klinis Diabetes di kota lain
- Boston, MA23 studi
- Houston, TX16 studi
- Chicago, IL15 studi
- Durham, NC14 studi
- Aurora, CO14 studi
- Baltimore, MD13 studi
- Philadelphia, PA12 studi
- San Diego, CA10 studi
- Los Angeles, CA10 studi
- Indianapolis, IN10 studi
- Washington, DC10 studi
- Queens, NY9 studi
Studi lain di New York City
- Kanker Payudara136 studi
- Kanker Paru Non-Sel Kecil121 studi
- Kanker (semua jenis)109 studi
- Kanker Prostat103 studi
- Kanker Metastatik93 studi
- Kanker Kolorektal78 studi
- Kanker Ovarium69 studi
- Kanker Paru60 studi
- Mieloma Multipel60 studi
- Kanker Pankreas60 studi
- Kanker Endometrium52 studi
- Leukemia Mieloid Akut51 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.